OBJECTIVE: The syndrome of cerebellar ataxia with bilateral vestibulopathy was delineated in 2004. Sensory neuropathy was mentioned in 3 of the 4 patients described. We aimed to characterize and estimate the frequency of neuropathy in this condition, and determine its typical MRI features. METHODS: Retrospective review of 18 subjects (including 4 from the original description) who met the criteria for bilateral vestibulopathy with cerebellar ataxia. RESULTS: The reported age at onset range was 39-71 years, and symptom duration was 3-38 years. The syndrome was identified in one sibling pair, suggesting that this may be a late-onset recessive disorder, although the other 16 cases were apparently sporadic. All 18 had sensory neuropathy with absent sensory nerve action potentials, although this was not apparent clinically in 2, and the presence of neuropathy was not a selection criterion. In 5, the loss of pinprick sensation was virtually global, mimicking a neuronopathy. However, findings in the other 11 with clinically manifest neuropathy suggested a length-dependent neuropathy. MRI scans showed cerebellar atrophy in 16, involving anterior and dorsal vermis, and hemispheric crus I, while 2 were normal. The inferior vermis and brainstem were spared. CONCLUSIONS: Sensory neuropathy is an integral component of this syndrome. It may result in severe sensory loss, which contributes significantly to the disability. The MRI changes are nonspecific, but, coupled with loss of sensory nerve action potentials, may aid diagnosis. We propose a new name for the condition: cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome (CANVAS).
OBJECTIVE: The syndrome of cerebellar ataxia with bilateral vestibulopathy was delineated in 2004. Sensory neuropathy was mentioned in 3 of the 4 patients described. We aimed to characterize and estimate the frequency of neuropathy in this condition, and determine its typical MRI features. METHODS: Retrospective review of 18 subjects (including 4 from the original description) who met the criteria for bilateral vestibulopathy with cerebellar ataxia. RESULTS: The reported age at onset range was 39-71 years, and symptom duration was 3-38 years. The syndrome was identified in one sibling pair, suggesting that this may be a late-onset recessive disorder, although the other 16 cases were apparently sporadic. All 18 had sensory neuropathy with absent sensory nerve action potentials, although this was not apparent clinically in 2, and the presence of neuropathy was not a selection criterion. In 5, the loss of pinprick sensation was virtually global, mimicking a neuronopathy. However, findings in the other 11 with clinically manifest neuropathy suggested a length-dependent neuropathy. MRI scans showed cerebellar atrophy in 16, involving anterior and dorsal vermis, and hemispheric crus I, while 2 were normal. The inferior vermis and brainstem were spared. CONCLUSIONS:Sensory neuropathy is an integral component of this syndrome. It may result in severe sensory loss, which contributes significantly to the disability. The MRI changes are nonspecific, but, coupled with loss of sensory nerve action potentials, may aid diagnosis. We propose a new name for the condition: cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome (CANVAS).
Authors: Giovanni Stevanin; Naima Bouslam; Stéphane Thobois; Hamid Azzedine; Lucas Ravaux; Anne Boland; Martin Schalling; Emmanuel Broussolle; Alexandra Dürr; Alexis Brice Journal: Ann Neurol Date: 2004-01 Impact factor: 10.422
Authors: David J Szmulewicz; Catriona A McLean; Michael L Rodriguez; Andrew M Chancellor; Stuart Mossman; Duncan Lamont; Leslie Roberts; Elsdon Storey; G Michael Halmagyi Journal: Neurology Date: 2014-03-28 Impact factor: 9.910
Authors: David J Szmulewicz; Leslie Roberts; Catriona A McLean; Hamish G MacDougall; G Michael Halmagyi; Elsdon Storey Journal: Neurol Clin Pract Date: 2016-02
Authors: O Gebus; S Montaut; B Monga; T Wirth; C Cheraud; C Alves Do Rego; I Zinchenko; G Carré; M Hamdaoui; G Hautecloque; L Nguyen-Them; B Lannes; J B Chanson; O Lagha-Boukbiza; M C Fleury; D Devys; G Nicolas; G Rudolf; M Bereau; M Mallaret; M Renaud; C Acquaviva; M Koenig; M Koob; S Kremer; I J Namer; C Cazeneuve; A Echaniz-Laguna; C Tranchant; Mathieu Anheim Journal: J Neurol Date: 2017-05-06 Impact factor: 4.849
Authors: Carolin K Scriba; Sarah J Beecroft; Joshua S Clayton; Andrea Cortese; Roisin Sullivan; Wai Yan Yau; Natalia Dominik; Miriam Rodrigues; Elizabeth Walker; Zoe Dyer; Teddy Y Wu; Mark R Davis; David C Chandler; Ben Weisburd; Henry Houlden; Mary M Reilly; Nigel G Laing; Phillipa J Lamont; Richard H Roxburgh; Gianina Ravenscroft Journal: Brain Date: 2020-10-01 Impact factor: 13.501
Authors: Florian Bodranghien; Amy Bastian; Carlo Casali; Mark Hallett; Elan D Louis; Mario Manto; Peter Mariën; Dennis A Nowak; Jeremy D Schmahmann; Mariano Serrao; Katharina Marie Steiner; Michael Strupp; Caroline Tilikete; Dagmar Timmann; Kim van Dun Journal: Cerebellum Date: 2016-06 Impact factor: 3.847
Authors: Alba Marina Milá de la Roca-Morales; Joan F Andreo-Marroig; Sofía Santos-Pérez; Andrés Soto-Varela Journal: J Int Adv Otol Date: 2018-04 Impact factor: 1.017